Advertisement
Most Read Articles
>> 'Studzmen' screens at Midtown Art Cinema this Thursday>> Local lesbian attorney Kathleen Womack elected to state bar's Board of Governors
>> DJs Vicki Powell, Chris Griswold to spin Atlanta Pride Kickoff Party
>> Minnesota governor to sign marriage equality bill today
>> Atlanta Pride announces 'Stonewall Month' schedule of events
Advertisement
LGBT Blogroll
-
No resolution yet on inclusion of LGBT partners in immigration bill
LGBTQ Nation | 20 May 2013 | 10:00 pm
-
Conner Habib On His High School Conquests, The Sexiest Pastry Chef & More!
Queerty | 20 May 2013 | 7:20 pm
-
Marriage Equality Round-Up: Illinois, UK
The Bilerico Project | 20 May 2013 | 5:30 pm
-
NEW YORK CITY: West Village Streets Closed For Massive Anti-Hate Crimes Rally"Say His Name: MARK CARSON!"
Joe. My. God. | 20 May 2013 | 4:48 pm
-
Sally Ride To Receive Presidential Medal Of Freedom
On Top Magazine Headlines | 20 May 2013 | 4:19 pm
Advertisement
| HIV researcher moves forward with vaccine trial |
| by Ryan Watkins | ||||
| December 13, 2011 17:45 | ||||
|
GeoVax Labs, an Atlanta-based biotechnology company, today announced a major milestone in its quest to eliminate the HIV virus, as the first patient has been inoculated with the company's HIV/AIDS vaccine following success in post-vaccine viral control in primates. The company's vaccine is aimed at stimulating the body's immune system to resist the spread of infection. "Dosing the first study participant marks a major milestone for our Phase 1/2 clinical trial. We are pleased to have the AIDS Research Consortium of Atlanta, the Alabama Vaccine Research Center at the University of Alabama, Birmingham, and the AIDS Research Alliance of Los Angeles participating in the trial,” said Robert McNally, president and CEO of GeoVax Labs, in a prepared statement. “These three trial sites are actively seeking persons who are interested in and fit the criteria for the study," McNally added. GeoVax is currently enrolling participants in the clinical trial, which is being conducted at the AIDS Research Consortium of Atlanta, the company announced. For more information on GeoVax and for information on signing up for its clinical trial, visit www.geovax.com.
|
